Trial Profile
A retrospective study evaluating effect of Rivaroxaban and Apixaban on Calcineurin Inhibitors Exposure.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2017
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Rivaroxaban (Primary) ; Ciclosporin; Tacrolimus
- Indications Embolism; Thrombosis
- Focus Pharmacokinetics
- 15 Dec 2017 New trial record